Dental Implants with Diabetes — Downey, CA
Diabetes isn’t a disqualifier.
Uncontrolled diabetes is.
Get your A1C under 7.5 and I can place implants in you. Here’s the honest workflow.
The Status Quo
Why most offices turn diabetic patients away.
Controlled diabetes is not a disqualifier: a 2023 systematic review and meta-analysis in the International Journal of Implant Dentistry found no statistically significant survival difference between well-controlled diabetic patients and non-diabetic controls. Yet we’ve had 47 patients walk through our doors in the last two years carrying a printed-out “sorry, you’re not a candidate” letter from another implant office, and every single one of them was diabetic. None of them were actually disqualified — they had been turned away by a practice that learned implants in school 18 years ago, when the literature said 12–15% failure in diabetic patients.
That number is outdated. A 2021 systematic review and meta-analysis in Clinical Oral Investigations found no significant difference in implant survival between controlled Type 2 diabetics and non-diabetic patients — the relative risk came out essentially even. Modern protocols — UV-activated titanium surfaces, autologous PRP, tighter glycemic targets, and longer integration windows — are built to protect that baseline, and you can see how we define and measure implant success for every patient, diabetic or not. The published meta-analyses agree: well-controlled diabetes (A1C under 7.5) is no longer a meaningful failure risk.
Diabetes is one of several conditions that get patients wrongly turned away. If you’re weighing more than one risk factor, start with whether you’re a candidate for dental implants at all, then read the condition-specific pages — implants with osteoporosis or bone-density medication, how smoking changes implant healing, and placing implants when you’ve already lost bone. The mechanism in most of them is the same one as diabetes: blood supply to the bone.
So why do they still refuse? Not because your case is unsafe — because they lack the tools to take a patient who heals 15% slower, so a rejection letter is easier than the work. That’s a business decision, not a clinical one, and we want diabetic patients to know the difference.
Why we don’t turn you away
Three reasons we accept patients others won’t.
Each one traces back to a tool most offices skip — current data, surface chemistry, and your own PRP.
They learned implants on old data
Most offices studied implants in school using early-2000s papers, when diabetic failure ran 12–15%. The literature has moved. Newer surface-treatment protocols put the controlled-diabetic failure rate within 1–2 points of the non-diabetic baseline — they’re screening you out on numbers that expired a decade ago.
They can’t fix slow healing
High blood sugar genuinely slows osteoblast activity and blood supply to the bone. The fix isn’t to refuse you — it’s to verify glycemic control first, then use UV-activated titanium and your own PRP to drive circulation back into the site. A practice without that chemistry has no margin, so it screens you out at the front desk.
No PRP, no UV, no LANAP
Diabetes is mostly a blood-supply problem — and blood is what carries the stem cells, growth factors, and white cells that fight infection and build bone. Without photofunctionalized titanium, Vampire PRP, and a laser to reverse early gum trouble, an office has nothing to offer a slower-healing patient but a rejection letter.
The Threshold
The A1C number, and what we ask of your physician.
Under 7.5: green light. At this level a controlled diabetic heals almost like a non-smoker. We proceed with the standard diabetic protocol — UV activation, PRP, 12–14 week integration, follow-up every 2–3 weeks for the first three months. About 73% of our diabetic patients fall in this band.
7.5 to 8.5: we proceed with caution. Longer integration window (14–16 weeks), more aggressive antibiotic coverage, follow-up weekly for the first month. We have a frank conversation about the elevated risk and document it in your consent. Roughly 16% of our diabetic patients are in this band.
8.5 to about 9: still possible, with consent. Because UV-activated titanium drives extra blood flow into the site, I can often place at this level — but only with a signed acknowledgment that the implant carries a higher chance of failing, and a promise from us to redo it if it does. Over 9 I’d rather hold for 90 days, get your numbers in range, and place a case built to last 25 years than rush one that fails at year three.
From your physician we need one page: a current A1C lab value (within 90 days), a fasting glucose number, a list of your current medications and doses, and a one-line statement that you’re stable on your current regimen. We don’t need a full medical records release — just enough to plan around your biology.
The diabetic-implant workflow
Five steps. One doctor. Two extra precautions you won’t find elsewhere.
- 01
Pre-clearance: A1C, fasting glucose, physician sign-off
We require a current A1C (within 90 days) and a one-page note from your physician confirming you’re stable on your current regimen. My target is A1C under 7.5 — between 7.5 and 8.5 we proceed with extra precautions, and with UV-activated implants I can often go up to nearly 9 with signed consent. Over 9 we ask you to work with your physician first. Most diabetic patients who come to us are already in range, or just a few months of tighter control away from it.
- 02
Day-of-surgery glucose protocol
Fingerstick on arrival. We will not place implants if your fasting glucose is over 200 mg/dL that morning — we reschedule rather than risk the case. Pre-operative antibiotic (amoxicillin 2g, or clindamycin if allergic). IV sedation is offered but not required.
- 03
UV-activated titanium + your own PRP (the Vampire protocol)
We photofunctionalize the implant under UV light for about 12 minutes before placement — this restores the surface hydrophilicity that titanium loses sitting on a shelf. Then we draw your blood, spin it for PRP, and bathe the implant in your own growth factors. The UCLA research my professor Dr. Ogawa published shows photofunctionalized surfaces achieve 50–100% more bone-to-implant contact. In diabetic bone, that extra circulation is the whole game.
- 04
Tight post-op monitoring on the seal
We see you at 48 hours, 1 week, 3 weeks, 6 weeks, and 12 weeks — about twice the cadence of a non-diabetic case. What I’m watching for is the gum: any redness or bleeding around the implant, because implants rarely hurt and won’t warn you. Caught at the inflammation stage, early gum trouble is reversible — and we have an Nd:YAG laser (LANAP) that kills the bacteria and rebuilds the keratinized seal if it ever starts to slip.
- 05
Final crown, balanced bite, ongoing hygiene
Once integration is verified at 12–14 weeks, we restore with monolithic zirconia, covered by our 10-year biological warranty. Then we balance your occlusion — like rotating the wheels on a car — so force runs straight down the implant, not side-to-side, which is what actually loses bone over the years. We see diabetic implant patients three times a year, not twice, so we catch any peri-implant shift early.
What the Evidence Says
Controlled diabetes, comparable outcomes.
A1C < 7.5
At controlled glucose, published meta-analyses find implant survival comparable to non-diabetic patients — no meaningful failure-risk difference.
~1.0
Relative risk of failure for controlled Type 2 diabetics vs. non-diabetics in a 2021 systematic review — essentially even.
14 wks
Typical integration window I plan for with UV + PRP — a longer, more closely watched timeline tuned to slower-healing diabetic bone.
What the data actually says
“Below an A1C of 7.5 with stable control, a diabetic patient places almost exactly like a non-smoker. Diabetes is really a blood-supply problem — and UV-activated implants plus the patient’s own PRP put that circulation back, which is exactly what the slower wound healing needs.”
The ADA reports a 90 to 95% implant success rate over 10 years when placement protocols are followed, including in medically managed diabetic patients. The AAID confirms that more than 3 million Americans now have implants and that well-controlled diabetes is no longer considered a meaningful risk factor for failure. A 2023 systematic review and meta-analysis in the International Journal of Implant Dentistry found no statistically significant difference in implant survival between well-controlled diabetic patients and non-diabetic controls, with most failures concentrated in the poorly controlled, higher-A1C group. At 5D Smiles, that is exactly the workflow: UV activation, PRP, and five follow-up visits in the first 14 weeks.
Clinical references
- American Dental Association. Diabetes and oral health: clinical guidance.
- American Academy of Implant Dentistry. Implant candidacy with controlled diabetes.
- Al Ansari Y, et al. (2023), International Journal of Implant Dentistry. HbA1c level and dental implant survival: a systematic review and meta-analysis.
Frequently asked
About implants with diabetes
- A1C under 7.5 is my green light — at that level a controlled diabetic heals almost like a non-smoker. Between 7.5 and 8.5 we proceed with extra precautions: a longer integration window, more frequent follow-ups, and a frank conversation about elevated risk. Because we use UV-activated titanium to drive blood flow into the site, I can often work up to nearly A1C 9 with signed consent that the implant may fail — and we are happy to redo it. Over 9, we ask you to work with your physician first and recheck in 90 days.
Take 2 minutes
Bring your A1C. We’ll bring honesty.
Two minutes of questions, then Dr. Qiu personally reviews your case within one business day. If your numbers aren’t ready, we’ll tell you exactly what to do — not just turn you away.
Or call (562) 923-4538
Your Implant Dentist
The doctor in the room is the one who does everything.
When you book a consult, you're not meeting a sales coordinator. You're meeting me. I'll personally read your CBCT, draft your treatment plan, and quote your exact price — start to finish.
— Dr. Henry Qiu, DDS
UCLA Trained · DIO Implant Faculty & Instructor